Your browser doesn't support javascript.
loading
Establishment and performance analysis of a new multiplex detection method for influenza an and B virus antigen.
Xia, Cheng-Jing; Li, Bao-Hua; Guo, Yan-Ni; Zhou, Xiao-He; Zhang, Run-Ling; Niu, Ying-No.
Afiliação
  • Xia CJ; Department of Clinical Laboratory, West Wing, Shenzhen Hospital (Guangming) of University of Chinese Academy of Sciences, Shenzhen 518106, Guangdong Province, China cjxia1976@163.com.
  • Li BH; Department of Clinical Laboratory, West Wing, Shenzhen Hospital (Guangming) of University of Chinese Academy of Sciences, Shenzhen 518106, Guangdong Province, China.
  • Guo YN; Department of Clinical Laboratory, West Wing, Shenzhen Hospital (Guangming) of University of Chinese Academy of Sciences, Shenzhen 518106, Guangdong Province, China.
  • Zhou XH; Department of Clinical Laboratory, West Wing, Shenzhen Hospital (Guangming) of University of Chinese Academy of Sciences, Shenzhen 518106, Guangdong Province, China.
  • Zhang RL; Department of Clinical Laboratory, West Wing, Shenzhen Hospital (Guangming) of University of Chinese Academy of Sciences, Shenzhen 518106, Guangdong Province, China.
  • Niu YN; Laboratory, Nanjing Vazyme Biotech Co. Ltd, Nanjing 210033, Jiangsu Province, China.
World J Clin Cases ; 12(23): 5338-5345, 2024 Aug 16.
Article em En | MEDLINE | ID: mdl-39156089
ABSTRACT

BACKGROUND:

Influenza A and B virus detection is pivotal in epidemiological surveillance and disease management. Rapid and accurate diagnostic techniques are crucial for timely clinical intervention and outbreak prevention. Quantum dot-encoded microspheres have been widely used in immunodetection. The integration of quantum dot-encoded microspheres with flow cytometry is a well-established technique that enables rapid analysis. Thus, establishing a multiplex detection method for influenza A and B virus antigens based on flow cytometry quantum dot microspheres will help in disease diagnosis.

AIM:

To establish a codetection method of influenza A and B virus antigens based on flow cytometry quantum dot-encoded microsphere technology, which forms the foundation for the assays of multiple respiratory virus biomarkers.

METHODS:

Different quantum dot-encoded microspheres were used to couple the monoclonal antibodies against influenza A and B. The known influenza A and B antigens were detected both separately and simultaneously on a flow cytometer, and the detection conditions were optimized to establish the influenza A and B antigen codetection method, which was utilized for their detection in clinical samples. The results were compared with the fluorescence quantitative polymerase chain reaction (PCR) method to validate the clinical performance of this method.

RESULTS:

The limits of detection of this method were 26.1 and 10.7 pg/mL for influenza A and B antigens, respectively, which both ranged from 15.6 to 250000 pg/mL. In the clinical sample evaluation, the proposed method well correlated with the fluorescent quantitative PCR method, with positive, negative, and overall compliance rates of 57.4%, 100%, and 71.6%, respectively.

CONCLUSION:

A multiplex assay for quantitative detection of influenza A and B virus antigens has been established, which is characterized by high sensitivity, good specificity, and a wide detection range and is promising for clinical applications.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article